Sophiris Bio (SPHS)

Add to Watchlists
Create an Alert
0.99 -0.01  -1.00% NASDAQ May 27, 20:00 Delayed 2m USD
View Full Chart
SPHS Price Chart
View All Performance Charts

SPHS Total Returns Comparison

Advertisement
Edit

Profile

  • URL: http://www.sophirisbio.com
  • Investor Relations URL: http://investor.sophirisbio.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Next Earnings Release: N/A
  • Last Earnings Release: N/A
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Profile: Sophiris Bio Inc is a clinical-stage biopharmaceutical company. The Company is engaged in research and development of products for the treatment of urological diseases. It is currently developing PRX302 for treatment of benign prostatic hyperplasia.

SPHS Comparables

Edit

SPHS Excel Add-In Codes

  • Name: =YCI("SPHS","name")
  • Description: =YCI("SPHS","description")
  • Sector: =YCI("SPHS","sector")
  • Industry: =YCI("SPHS","industry")
  • Est. Current Fiscal Year End: =YCI("SPHS","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.